Drawing for LYSEBLUE

USPTO serial 78755307

LYSEBLUE

Reviewed by CopyMark Law Group

Reg. 3301872Status 800Renewal
Filing date
Status date
Registration date
Oct 2, 2007
Examiner
GRIFFIN, JAMES
Law office
GENERIC WEB UPDATE

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with LYSEBLUE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Victoria Friedman

Victoria Friedman Dennemeyer & Associates, LLC230 W. Monroe St.Suite 2100Chicago, IL 60606

Goods and services

ClassDescriptionStatusFirst use
001Chemical, [biochemical and biotechnological] products for industrial and scientific purposes, namely, [solutions for protein processing, buffers, ]reagents, indicators, lysis compositions,[ wash compositions, binding compositions, enzymes,] and solvents for the preparation of samples, the modification and manipulation of cells as well as performing[ marking], separation, isolation, purification[, reproduction] and analysis methods for biopolymers, in particular nucleic acids,[ proteins, macromolecules and biologically active substances;] diagnostic preparations, except for human medical and veterinary medical purposes; reagents and solvents, not for medical or veterinary purposes, and in particular for the preparation of samples, the modification and manipulation of cells as well as for performing[ marking], separation, isolation, purification,[reproduction] and analysis methods for biopolymers, in particular nucleic acids[, proteins, macromolecules and biologically active substances; kits comprising products for scientific and research diagnostic purposes, composed of solutions for protein processing, buffers, reagents, indicators, lysis compositions, wash compositions, binding compositions, enzymes, and solvents, and in particular for the preparation of samples, the modification and manipulation of cells as well as for the marking, separation, isolation, purification, reproduction and analysis of biopolymers, in particular nucleic acids, proteins, macromolecules, and biologically active substances in particular nucleic acids from biological and biochemical sample materia]lACTIVE—
005[Products for medical and veterinary medical purposes, in particular diagnostic preparations, in particular for the preparation of samples, the modification and manipulation of cells and for the marking, separation, isolation, purification and reproduction and the analysis of biopolymers, in particular nucleic acids, proteins,macromolecules and biologically active substances; chemical, biochemical and biotechnological products, in particular reagents and solvents for medical and veterinary use for the preparation of samples, the modification and the manipulation of cells as well as for performing marking, separation, isolation, purification, reproduction and analysis methods for biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances for diagnostic purposes; kits comprising products for medical and veterinary medical diagnostic purposes composed of solutions for protein processing, buffers, reagents, indicators, lysis compositions, wash compositions, binding compositions, enzymes, solvents, and binding supports, in particular for the preparation of samples, the modification and manipulation of cells and for marking, separation, isolation, purification, reproduction and analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids from biological or biochemical sample material]SECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 2, 2026REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
May 3, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 3, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
May 3, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 3, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 3, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 3, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 21, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 21, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 21, 2021ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jul 21, 2021EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jul 21, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 21, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 21, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 13, 2017NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
Sep 13, 2017RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Sep 13, 201789AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Sep 11, 2017E89RTEAS SECTION 8 & 9 RECEIVED—
Oct 2, 2016REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Oct 3, 2013NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Oct 3, 2013C15PREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Oct 3, 2013APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 1, 2013815FREGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED—
Oct 1, 2013E815TEAS SECTION 8 & 15 RECEIVED—
Oct 2, 2007R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 17, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 27, 2007NPUBNOTICE OF PUBLICATION—
May 3, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 2, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 2, 2007ACECAMENDMENT FROM APPLICANT ENTERED—
May 2, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 2, 2007ALIEASSIGNED TO LIE—
Apr 3, 2007MAILPAPER RECEIVED—
Jan 11, 2007GNSLLETTER OF SUSPENSION E-MAILED—
Jan 11, 2007CNSLSUSPENSION LETTER WRITTEN—
Dec 27, 2006ACECAMENDMENT FROM APPLICANT ENTERED—
Nov 24, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 24, 2006MAILPAPER RECEIVED—
May 23, 2006GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 23, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 16, 2006DOCKASSIGNED TO EXAMINER—
Nov 22, 2005NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance